These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17487760)

  • 21. Universal screening and drug treatment of dyslipidemia in children and adolescents.
    Psaty BM; Rivara FP
    JAMA; 2012 Jan; 307(3):257-8. PubMed ID: 22174386
    [No Abstract]   [Full Text] [Related]  

  • 22. The treatment of dyslipidemia--what's left in the pipeline?
    Rau O; Zettl H; Popescu L; Steinhilber D; Schubert-Zsilavecz M
    ChemMedChem; 2008 Feb; 3(2):206-21. PubMed ID: 17963209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid-lowering therapy in patients with peripheral arterial disease.
    Collins P; Brittenden J
    Vasc Med; 2004 Nov; 9(4):303-6. PubMed ID: 15678623
    [No Abstract]   [Full Text] [Related]  

  • 24. Statins in patients with chronic kidney disease: a double-edged sword?
    Kassimatis TI; Konstantinopoulos PA
    J Am Coll Cardiol; 2008 Nov; 52(20):1679; author reply 1680. PubMed ID: 18992660
    [No Abstract]   [Full Text] [Related]  

  • 25. Optimal medical management of peripheral arterial disease.
    Paraskevas KI; Hamilton G; Mikhailidis DP; Liapis CD
    Vasc Endovascular Surg; 2007; 41(1):87. PubMed ID: 17277251
    [No Abstract]   [Full Text] [Related]  

  • 26. How many claudicants should be prescribed statins?
    Harrison EM; Holdsworth RJ
    Eur J Vasc Endovasc Surg; 2003 Apr; 25(4):367-8. PubMed ID: 12651177
    [No Abstract]   [Full Text] [Related]  

  • 27. [Preadmission use of statins as treatment for strokes].
    González-Hernández A; López-Fernández JC; Fabre-Pi O; Cubero A
    Rev Neurol; 2007 Dec 1-15; 45(11):702-3. PubMed ID: 18050107
    [No Abstract]   [Full Text] [Related]  

  • 28. The use of lipid-lowering drug therapy in children and adolescents.
    Avis HJ; Vissers MN; Wijburg FA; Kastelein JJ; Hutten BA
    Curr Opin Investig Drugs; 2009 Mar; 10(3):224-31. PubMed ID: 19333879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid management in chronic kidney disease, hemodialysis, and transplantation.
    Montague T; Murphy B
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):223-34. PubMed ID: 19217521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in patients with diabetes mellitus and mixed dyslipidemia.
    Athyros VG; Kakafika AI; Karagiannis A; Mikhailidis DP
    Am J Cardiol; 2008 Jun; 101(11):1679-80. PubMed ID: 18489951
    [No Abstract]   [Full Text] [Related]  

  • 31. Improving physician adherence to cholesterol management guidelines.
    Cabana MD; Davis MM
    Manag Care; 2002 Oct; 11(10 Suppl):18-22. PubMed ID: 18575211
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of statins on renal function in patients with peripheral arterial disease.
    Paraskevas KI; Bessias N; Tzorbatzoglou J; Mikhailidis DP; Andrikopoulos V
    Vasc Endovascular Surg; 2008 Dec-2009 Jan; 42(6):620-1; author reply 621. PubMed ID: 19056802
    [No Abstract]   [Full Text] [Related]  

  • 33. What works and in whom? A simple, easily applied, evidence-based approach to guidelines for statin therapy.
    Ridker PM
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):592-3. PubMed ID: 22811504
    [No Abstract]   [Full Text] [Related]  

  • 34. Statin-fibrate combination therapy.
    Feeman WE
    Am J Cardiol; 2008 May; 101(10):1521. PubMed ID: 18471475
    [No Abstract]   [Full Text] [Related]  

  • 35. Fenofibrate profiled as the fibrate with additional new data, supporting its use with statins in the European Medicines Agency recommendations.
    Cardiovasc J Afr; 2011; 22(1):55. PubMed ID: 21298212
    [No Abstract]   [Full Text] [Related]  

  • 36. It's time for CHUMP to change.
    Mejia V; Carver JR
    J Invasive Cardiol; 2005 Oct; 17(10):521. PubMed ID: 16204744
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of dyslipidemias in patients with diabetes and chronic kidney disease.
    Molitch ME
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1090-9. PubMed ID: 17699330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Will obesity increase the proportion of children and adolescents recommended for a statin?
    McCrindle BW; Tyrrell PN; Kavey RE
    Circulation; 2013 Nov; 128(19):2162-5. PubMed ID: 24190936
    [No Abstract]   [Full Text] [Related]  

  • 39. CVD risk factors in rural women.
    Roddy SJ; Walker SN; Larsen J; Lindsey A; Shurmur S; Yates B
    Nurse Pract; 2007 Jun; 32(6):53-5. PubMed ID: 17557029
    [No Abstract]   [Full Text] [Related]  

  • 40. Cholesterol screening in children: makes sense but what is the impact?
    Rohatgi A
    Future Cardiol; 2010 May; 6(3):275-80. PubMed ID: 20462333
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.